Trial Profile
Ganciclovir 0.15% Ophthalmic Gel in the Treatment of Adenovirus Keratoconjuntivitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 May 2011
Price :
$35
*
At a glance
- Drugs Ganciclovir (Primary)
- Indications Adenovirus infections; Infectious keratoconjunctivitis
- Focus Therapeutic Use
- 09 May 2011 New trial record